Naphthaline derivatives useful as histamine-3-receptor ligands

Details for Australian Patent Application No. 2005249196 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Nettekoven, Matthias Heinrich; Roche, Olivier; Plancher, Jean-Marc; Raab, Susanne; Hertel, Cornelia; Gatti McArthur, Silvia; Schuler, Franz; RodriguezSarmiento, Rosa Maria

Agent Spruson & Ferguson

Pub. Number AU-B-2005249196

PCT Pub. Number WO2005/117865

Priority 04102460.5 02.06.04 EP

Filing date 24 May 2005

Wipo publication date 15 December 2005

Acceptance publication date 9 June 2011

International Classifications

C07D 203/18 (2006.01) Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom

C07D 205/04 (2006.01) Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom

C07D 207/06 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 207/12 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 207/14 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 209/44 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 211/22 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 211/38 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 211/42 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 211/46 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 217/06 (2006.01) Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

C07D 223/04 (2006.01) Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom

C07D 295/088 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 295/092 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 295/192 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 401/10 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

4 January 2007 PCT application entered the National Phase

  PCT publication WO2005/117865 Priority application(s): WO2005/117865

9 June 2011 Application Accepted

  Published as AU-B-2005249196

6 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005249200-Treatment with oxaliplatin and an EGFR-inhibitor

2005249192-Low-foaming aqueous formulations used for crop protection